Skip to content
healthcare.dev

ROPIVACAINE HYDROCHLORIDE

NDC 43066-019, ropivacaine hydrochloride, injection, from Baxter Healthcare Corporation.

Product NDC
43066-019
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION
Route
EPIDURAL, INFILTRATION, PERINEURAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212808
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43066-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROPIVACAINE HYDROCHLORIDE5 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]

Package NDCNDC-11Package
43066-019-104306600191010 VIAL in 1 CARTON (43066-019-10) / 20 mL in 1 VIAL (43066-019-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/781d4b7f-7556-4695-8d48-7772d7a0d8e9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=43066-019

Use it

Look up 43066-019 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43066-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43066-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.